newer antidepressants NAUREX Glyx-13 Recognized as one of the best projects Windhover Neuroscience 10 To Watch NAUREX Inc., a company developing clinical stage innovative treatments for depression and CNS disorders, reported that its clinical candidate for the treatment of depression, Glyx-13 and its second generation NRX-1050 series have been selected for inclusion in the list of Windhover 's "The 10 projects of Neuroscience monitor …
how to tackle a drug addcition problem